Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

Similar articles for PubMed (Select 8177055)

2.
3.

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.

Yilmaz M, Biri A, Karakoç A, Törüner F, Bingöl B, Cakir N, Tiras B, Ayvaz G, Arslan M.

J Endocrinol Invest. 2005 Dec;28(11):1003-8.

PMID:
16483179
4.

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.

Unlühizarci K, Keleştimur F, Bayram F, Sahin Y, Tutuş A.

Clin Endocrinol (Oxf). 1999 Aug;51(2):231-6.

PMID:
10468995
5.

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L.

Metabolism. 1999 Apr;48(4):511-9.

PMID:
10206447
6.

Metformin therapy in women with polycystic ovary syndrome.

Aruna J, Mittal S, Kumar S, Misra R, Dadhwal V, Vimala N.

Int J Gynaecol Obstet. 2004 Dec;87(3):237-41.

PMID:
15548396
7.

Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome.

Loverro G, Lorusso F, De Pergola G, Nicolardi V, Mei L, Selvaggi L.

Gynecol Endocrinol. 2002 Jun;16(3):217-24.

PMID:
12192894
8.

Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow.

Loverro G, Vicino M, Lorusso F, Vimercati A, Greco P, Selvaggi L.

Gynecol Endocrinol. 2001 Apr;15(2):142-9.

PMID:
11379011
9.

Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.

Kazerooni T, Dehghan-Kooshkghazi M.

Gynecol Endocrinol. 2003 Feb;17(1):51-6.

PMID:
12724019
11.

Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.

Wu J, Zhu Y, Jiang Y, Cao Y.

Gynecol Endocrinol. 2008 Jul;24(7):392-8. doi: 10.1080/09513590802217027.

PMID:
18608522
14.
15.

Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.

Pawelczyk L, Spaczynski RZ, Banaszewska B, Duleba AJ.

Eur J Obstet Gynecol Reprod Biol. 2004 Apr 15;113(2):209-13.

PMID:
15063962
16.

Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.

Mitkov M, Pehlivanov B, Terzieva D.

Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):93-8. Epub 2005 Dec 19.

PMID:
16360262
17.

[Role of hyperinsulinemia in pathogenesis of polycystic ovary syndrome and treatment by reduction of insulin secretion].

Wang A, Li M, Lu C.

Zhonghua Fu Chan Ke Za Zhi. 1998 Dec;33(12):731-4. Chinese.

PMID:
10806662
18.

Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome.

Chen MJ, Yang WS, Yang JH, Chen CL, Ho HN, Yang YS.

Hypertension. 2007 Jun;49(6):1442-7. Epub 2007 Mar 26.

19.

[Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].

Vrbíková J, Hill M, Stárka L, Cibula D, Snajderová M, Sulcová J, Vondra K, Bendlová B.

Cas Lek Cesk. 2001 Nov 8;140(22):688-94. Czech.

PMID:
11789058
20.

[Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].

Ye BL, Yang HY, Zhao JZ, Lin JJ, Lin WQ.

Zhonghua Fu Chan Ke Za Zhi. 2003 Dec;38(12):745-8. Chinese.

PMID:
14728846
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk